SCOLR Pharma, Inc. (DDD) Issued Fifth Drug Delivery Patent for CDT(R) Drug Delivery Platform  
6/18/2007 1:38:54 PM

BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD) today announced that the United States Patent and Trademark Office has issued SCOLR a fifth patent (#7,229,642) entitled “Amino acid modulated extended release dosage form”. This new patent is the third for SCOLR Pharma’s amino acid-based CDT® drug delivery platform.